Driscoll, C.B.; Rich, J.M.; Isaacson, D.; Nicolas, J.; Jiang, Y.; Mi, X.; Yang, C.; Kocsuta, V.; Goh, R.; Patel, N.;
et al. Tumor Necrosis Factor-Alpha Inhibitor Use and Malignancy Risk: A Systematic Review and Patient Level Meta-Analysis. Cancers 2025, 17, 390.
https://doi.org/10.3390/cancers17030390
AMA Style
Driscoll CB, Rich JM, Isaacson D, Nicolas J, Jiang Y, Mi X, Yang C, Kocsuta V, Goh R, Patel N,
et al. Tumor Necrosis Factor-Alpha Inhibitor Use and Malignancy Risk: A Systematic Review and Patient Level Meta-Analysis. Cancers. 2025; 17(3):390.
https://doi.org/10.3390/cancers17030390
Chicago/Turabian Style
Driscoll, Conor B., Jordan M. Rich, Dylan Isaacson, Joseph Nicolas, Yu Jiang, Xinlei Mi, Christopher Yang, Victoria Kocsuta, Regine Goh, Niti Patel,
and et al. 2025. "Tumor Necrosis Factor-Alpha Inhibitor Use and Malignancy Risk: A Systematic Review and Patient Level Meta-Analysis" Cancers 17, no. 3: 390.
https://doi.org/10.3390/cancers17030390
APA Style
Driscoll, C. B., Rich, J. M., Isaacson, D., Nicolas, J., Jiang, Y., Mi, X., Yang, C., Kocsuta, V., Goh, R., Patel, N., Li, E., Siddiqui, M. R., Meyers, T., Witte, J. S., Kachuri, L., Zhang, H., Beestrum, M., Silberman, P., Schaeffer, E. M.,
& Kundu, S. D.
(2025). Tumor Necrosis Factor-Alpha Inhibitor Use and Malignancy Risk: A Systematic Review and Patient Level Meta-Analysis. Cancers, 17(3), 390.
https://doi.org/10.3390/cancers17030390
